Boston Scientific has signed a $2 billion accelerated share-repurchase agreement with JPMorgan Chase as part of the medical-technology company's $5 billion stock-buyback program. Boston Scientific on ...
Original Image Link
Source:www.marketwatch.com
Original Image Link
Source:www.marketwatch.com
Posted: 2026-05-18 04:51:00

















